Literature DB >> 21693124

Presence of bioactive lysophosphatidic acid in renal effluent of rats with unilateral ureteral obstruction.

Toshihiko Tsutsumi1, Mika Adachi, Miki Nikawadori, Junichi Morishige, Akira Tokumura.   

Abstract

AIMS: Abnormal production of lysophosphatidic acid (LPA), an important lysophospholipid mediator, in the kidney was examined to participate in the pathogenesis of renal fibrosis in rats. The secretory lysophospholipase D activity of autotoxin was considered as a possible pathway for extracellular production of LPA in the pathological renal fluids. MAIN
METHODS: In this study of rats with unilateral ureteral obstruction for two weeks, we measured concentrations of LPA and its precursor, lysophosphatidylcholine stored in the urinary bladder and present in the swollen pelvis of the ligated kidney as well as the corresponding blood plasma by liquid chromatography-tandem mass spectrometry. KEY
FINDINGS: We found that concentrations of LPA and lysophosphatidylcholine accumulated in the effluent in the swollen pelvis of the ligated kidney of unilateral ureteral obstruction rats were much higher than those in the urinary bladder. The molecular species composition of LPA in the former was considerably different from that in the blood plasma, indicating the involvement of an additional source other than the blood circulation supplying LPA to the effluent in the swollen kidney. A potential mechanism is increased release of LPA from activated renal cells in the ureter-ligated kidney. SIGNIFICANCE: Both pathways for supply of extracellular LPA may participate in the induction and progression of renal tubulofibrosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21693124     DOI: 10.1016/j.lfs.2011.06.001

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Lysophosphatidic Acid Protects Against Endotoxin-Induced Acute Kidney Injury.

Authors:  Koryun Mirzoyan; Colette Denis; Audrey Casemayou; Marion Gilet; Dimitri Marsal; Dominique Goudounéche; Stanislas Faguer; Jean-Loup Bascands; Joost P Schanstra; Jean-Sébastien Saulnier-Blache
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

2.  Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor.

Authors:  Norihiko Sakai; Jerold Chun; Jeremy S Duffield; David Lagares; Takashi Wada; Andrew D Luster; Andrew M Tager
Journal:  Kidney Int       Date:  2016-12-04       Impact factor: 10.612

3.  Integrative phosphatidylcholine metabolism through phospholipase A2 in rats with chronic kidney disease.

Authors:  Yan-Ni Wang; Zhi-Hao Zhang; Hong-Jiao Liu; Zhi-Yuan Guo; Liang Zou; Ya-Mei Zhang; Ying-Yong Zhao
Journal:  Acta Pharmacol Sin       Date:  2022-08-03       Impact factor: 7.169

4.  Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease.

Authors:  Koryun Mirzoyan; Anna Baïotto; Aude Dupuy; Dimitri Marsal; Colette Denis; Claire Vinel; Pierre Sicard; Justine Bertrand-Michel; Jean-Loup Bascands; Joost P Schanstra; Julie Klein; Jean-Sébastien Saulnier-Blache
Journal:  J Physiol Biochem       Date:  2016-09-17       Impact factor: 4.158

5.  Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.

Authors:  Takashi Hirata; Stanley V Smith; Teisuke Takahashi; Noriyuki Miyata; Richard J Roman
Journal:  J Pharmacol Exp Ther       Date:  2020-12-04       Impact factor: 4.030

6.  The involvement of autotaxin in renal interstitial fibrosis through regulation of fibroblast functions and induction of vascular leakage.

Authors:  Norihiko Sakai; Gretchen Bain; Kengo Furuichi; Yasunori Iwata; Miki Nakamura; Akinori Hara; Shinji Kitajima; Akihiro Sagara; Taito Miyake; Tadashi Toyama; Koichi Sato; Shiori Nakagawa; Miho Shimizu; Shuichi Kaneko; Takashi Wada
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

7.  Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: Its possible protective role in renal fibrosis.

Authors:  Toshihiko Tsutsumi; Syougo Yamakawa; Akira Ishihara; Aimi Yamamoto; Tamotsu Tanaka; Akira Tokumura
Journal:  Toxicol Rep       Date:  2015-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.